Inovotion

La Tronche, France Founded: 2014 • Age: 12 yrs
Provider of in vivo oncology efficacy and toxicity assays for drug discovery and development
Request Access

About Inovotion

Inovotion is a company based in La Tronche (France) founded in 2014.. Inovotion offers products and services including In Vivo Oncology Assays, CAM Technology, and Toxicity Assays. Inovotion operates in a competitive market with competitors including Altis Biosystems, Toxys, ATANIS Biotech, BioTalentum and Foresee Biosystems, among others.

  • Headquarter La Tronche, France
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Inovotion Sas
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $57.05 K (USD), Grant

    Jun 30, 2017

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Inovotion

Inovotion offers a comprehensive portfolio of products and services, including In Vivo Oncology Assays, CAM Technology, and Toxicity Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Assays for evaluating drug efficacy and toxicity in oncology research.

Platform for studying tumor growth and metastasis in vivo models.

Services for assessing drug safety and target validation in medicine.

Funding Insights of Inovotion

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $57,046
  • First Round

    (01 Jan 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2017 Amount Grant - Inovotion Valuation

investors

Jan, 2017 Amount Grant - Inovotion Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Inovotion

Inovotion has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Inovotion

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Inovotion

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Inovotion Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Inovotion

Inovotion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altis Biosystems, Toxys, ATANIS Biotech, BioTalentum and Foresee Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of invitro platform for drug testing
domain founded_year HQ Location
In vitro genotoxicity testing services are provided using proprietary technology.
domain founded_year HQ Location
Developer of a cell-based assay for the diagnosis of allergies
domain founded_year HQ Location
Human stem-cell technologies for drug testing and toxicology are provided.
domain founded_year HQ Location
Developer of in vitro assays for detection of potential toxicity in drug discovery
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Inovotion

Frequently Asked Questions about Inovotion

When was Inovotion founded?

Inovotion was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is Inovotion located?

Inovotion is headquartered in La Tronche, France. It is registered at La Tronche, Auvergne-rhone-alpes, France.

Who is the current CEO of Inovotion?

Jean Viallet is the current CEO of Inovotion.

What does Inovotion do?

Inovotion was founded in 2014 in La Tronche, France, within the biotechnology sector focused on oncology. In vivo assays for efficacy and toxicity in drug discovery and development are offered by the company. Highly sensitive and reproducible assays for immuno-oncology programs are provided, along with monitoring of human tumor cell growth and metastatic dissemination. Operations support pharmaceutical research through these specialized services.

Who are the top competitors of Inovotion?

Inovotion's top competitors include Altis Biosystems, ABL Diagnostics and ATANIS Biotech.

What products or services does Inovotion offer?

Inovotion offers In Vivo Oncology Assays, CAM Technology, and Toxicity Assays.

Who are Inovotion's investors?

Inovotion has 2 investors. Key investors include European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available